SFM
HELP

Sphera Funds Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Sphera Funds Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
1,620,753
+633,663
+64% +$3.17M 1.4% 18
2026
Q1 		$4.74M Buy
987,090
+161,514
+20% +$1.04M 0.75% 48
2025
Q4 		$6.75M Buy
825,576
+455,200
+123% +$2.93M 1.31% 26
2025
Q3 		$2.18M Sell
370,376
-27,933
-7% -$198K 0.46% 68
2025
Q2 		$3.34M Sell
398,309
-128,913
-24% -$938K 0.78% 47
2025
Q1 		$3.34M Sell
527,222
-10,889
-2% -$94.3K 0.77% 41
2024
Q4 		$4.75M Sell
538,111
-395,114
-42% -$4.01M 0.86% 44
2024
Q3 		$8.3M Buy
933,225
+260,030
+39% +$2.57M 1.32% 23
2024
Q2 		$6.93M Hold
673,195
– – 0.95% 34
2024
Q1 		$10.6M Buy
+673,195
New +$9.73M 1.49% 24

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Sphera Funds Management's HELP Position: Q2 2026 in Review

Sphera Funds Management increased its Helus Pharma Inc. Common Stock (HELP) stake by 64% in Q2 2026, buying an estimated $3.17M and bringing the position to 1,620,753 shares worth $10.7M. The position accounts for 1.4% of the portfolio, ranked #18.

Sphera Funds Management first reported a position in HELP in Q1 2024 and has held it in 10 quarters since. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Sphera Funds Management held 1,620,753 shares of Helus Pharma Inc. Common Stock worth $10.7M as of Q2 2026.
  • Sphera Funds Management bought 633,663 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $3.17M.
  • Helus Pharma Inc. Common Stock made up 1.4% of Sphera Funds Management's portfolio in Q2 2026, its #18 holding.
  • Sphera Funds Management first reported a position in Helus Pharma Inc. Common Stock in Q1 2024 and has held it in 10 quarters since.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.